ncAA Incorporation In Yeast

GCEngine delivers in vivo ncAA incorporation in S. cerevisiae using orthogonal aaRS/tRNA pairs with UAG amber as the primary codon strategy and, where supported, quadruplet decoding. Standardized ratiometric reporters and host-specific process optimization (promoter strength, plasmid copy number, tRNA expression) are used to maximize yield and fidelity. For projects targeting higher sensitivity or expanded substrate scope, we offer collaborative OrthoRep-style aaRS evolution.

Introduction to ncAA Incorporation In Yeast

Yeast provides a eukaryotic translation environment with strong genetic tools and industrial familiarity, though ncAA incorporation efficiency has historically trailed E. coli due to eRF1 competition and context effects.  Recent advances in in vivo hypermutation/continuous evolution (e.g., OrthoRep) have markedly improved aaRS performance, with campaigns demonstrating ncAA-dependent translation approaching natural levels in certain cases. In practice, ncAA transport/uptake, promoter strength, tRNA gene/pol III expression and copy, and codon context all influence readouts; a structured optimization path plus matched controls and intact mass/LC–MS/MS verification are essential for robust results.

Fig.1 Evolved M. alvus aaRSs and their preferences for ncAAs. (Furuhata, Y., et al., 2024)

When to Prioritize Yeast?

• Rapid aaRS iteration in a eukaryotic context (e.g., OrthoRep continuous evolution) to accelerate optimization cycles.
• Target proteins requiring secretion, disulfide formation, or membrane localization, or plans to run yeast surface display + FACS functional screening.
• Need a faster, more cost-efficient in vivo validation and method-development path than mammalian cells while preserving key eukaryotic processing.

Our Services

We provide an in vivo ncAA incorporation program in S. cerevisiae using orthogonal aaRS/tRNA pairs. Start with quantitative baselining, then add targeted optimization or optional aaRS evolution as requested. Our team delivers the plan, the builds, and the readouts—plus transfer notes for display or secretion—so you can progress from pilot to production with fewer detours.

Reporter & Vector Architecture

• Choice of UAG amber (default) or quadruplet (feasibility-only), ratiometric RFP-linker-GFP or single-endpoint reporters.
• Promoter/backbone selection (e.g., CEN/ARS vs 2μ) aligned to stability and expression goals.

Orthogonal Pair Onboarding

• Import and validate bacterial/archaeal aaRS/tRNA pairs with +ncAA/−ncAA and omission/swap controls.
• Early assessment of permissivity and background; short-listing of viable pairs; schedule MS checkpoints.

ncAA Transport & Optimization

• Media/formulation and feed schedule design; evaluate transport limitations and co-solvents.
• Dose–response and time-course mapping to define operating window.

Fidelity & MS-Level Confirmation

• Expression of ncAA-bearing targets followed by intact‑mass and/or peptide-level LC-MS/MS to confirm site specificity and occupancy.
• Optional click-chemistry assays for bioorthogonal handles.

Contact Us

Unlock eukaryotic ncAA capability with measurable efficiency and fidelity gains. Contact us with your use case—display, secretion, or functional screening—and target ncAA panel. We will propose a staged plan with milestones, optional evolution tracks, timelines, and a transparent quote. Schedule a discovery call to begin optimizing today with data that scales beyond pilot experiments.

Reference

1. Furuhata, Y., et al., (2024). Directed evolution of aminoacyl-tRNA synthetases through in vivo hypermutation. bioRxiv: the preprint server for biology, 2024.09.27.615507.